17beta-estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization.

Paper

17beta-estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization.

Published 2005 · S. Ghisletti, C. Meda, A. Maggi

Molecular and cellular biology

Q1 SJR score

167

Citations

11

Influential Citations

Semantic Scholar

Abstract

Estrogen is an immunoregulatory agent, in that hormone deprivation increases while 17beta-estradiol (E2) administration blocks the inflammatory response; however, the underlying mechanism is still unknown. The transcription factor p65/relA, a member of the nuclear factor kappaB (NF-kappaB) family, plays a major role in inflammation and drives the expression of proinflammatory mediators. Here we report a novel mechanism of action of E2 in inflammation. We observe that in macrophages E2 blocks lipopolysaccharide-induced DNA binding and transcriptional activity of p65 by preventing its nuclear translocation. This effect is selectively activated in macrophages to prevent p65 activation by inflammatory agents and extends to other members of the NF-kappaB family, including c-Rel and p50. We observe that E2 activates a rapid and persistent response that involves the activation of phosphatidylinositol 3-kinase, without requiring de novo protein synthesis or modifying Ikappa-Balpha degradation and mitogen-activated protein kinase activation. Using a time course experiment and the microtubule-disrupting agent nocodazole, we observe that the hormone inhibits p65 intracellular transport to the nucleus. This activity is selectively mediated by estrogen receptor alpha (ERalpha) and not ERbeta and is not shared by conventional anti-inflammatory drugs. These results unravel a novel and unique mechanism for E2 anti-inflammatory activity, which may be useful for identifying more selective ligands for the prevention of the inflammatory response.

In Vitro Study

Highly Cited

Study Snapshot

17beta-estradiol inhibits inflammation by controlling NF-kappaB intracellular localization, a novel and unique mechanism for its anti-inflammatory activity.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

17beta-estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization.

Sign up to use Study Snapshot

References

Citations

Ovariectomy and Estradiol Supplementation Prevents Cyclophosphamide- and Doxorubicin-Induced Spatial Memory Impairment in Tumor-Bearing MMTV-PyVT Mice

Ovariectomy and estradiol supplementation can prevent chemotherapy-induced spatial memory impairments in breast cancer mice.

Menstruation-Related Angina—The Wee Hours

Menstruation-related anginas, such as cardiac syndrome X and catamenial angina, are caused by decreased estrogen levels, and reducing symptoms and improving quality of life can be achieved through nonpharmacological and pharmacological treatments.

Role of estrogen in treatment of female depression

Estrogen and its receptors play a crucial role in depression, contributing to its pathogenesis and treatment, potentially leading to new antidepressant drug development and alternative treatment options.

Global Interactome Mapping Reveals Pro-tumorigenic Interactions of NF-κB in Breast Cancer

NF-B inhibition in breast cancer leads to a rearrangement of pro-tumorigenic protein interactions, potentially offering therapeutic implications in tumors with high NF-B activity.

Stevioside attenuates bleomycin-induced pulmonary fibrosis by activating the Nrf2 pathway and inhibiting the NF-κB and TGF-β1/Smad2/3 pathways

Stevioside improves bleomycin-induced pulmonary fibrosis by activating the Nrf2 pathway, suppressing inflammation, and inhibiting EMT progression by blocking the TGF-1/Smad2/3 pathway.